中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2015年
21期
7-7,8
,共2页
顺尔宁%舒利迭气雾剂%支气管哮喘
順爾寧%舒利迭氣霧劑%支氣管哮喘
순이저%서리질기무제%지기관효천
Sulnin%Seretide evohaler%Bronchial asthma
目的:观察顺尔宁联合舒利迭气雾剂吸入治疗支气管哮喘的治疗效果,分析其价值。方法我院抽取2012年1月至2013年11月到医院治疗的支气管哮喘52例患者,按照不同方法平均分成两组:一组是对照组,另一组是观察组,每组各26例患者。应用予布地奈德气雾剂吸入方法对对照组进行治疗;应用顺尔宁联合舒利迭气雾剂吸入对观察组进行治疗。结果观察组和对照组肺功能指标变化情况,观察组的MMEF、PEF以及FEV1明显高于对照组,两组数据都比差异明显,统计学有意义(P<0.05)。应用ACT对两组治疗前后治疗效果进行评分,观察组经过治疗后由于对照组,两组数据都比差异明显,统计学有意义(P<0.05)。结论临床中应用顺尔宁联合舒利迭气雾剂吸入治疗支气管哮喘获得满意的治疗效果,值得临床研究推广使用。
目的:觀察順爾寧聯閤舒利迭氣霧劑吸入治療支氣管哮喘的治療效果,分析其價值。方法我院抽取2012年1月至2013年11月到醫院治療的支氣管哮喘52例患者,按照不同方法平均分成兩組:一組是對照組,另一組是觀察組,每組各26例患者。應用予佈地奈德氣霧劑吸入方法對對照組進行治療;應用順爾寧聯閤舒利迭氣霧劑吸入對觀察組進行治療。結果觀察組和對照組肺功能指標變化情況,觀察組的MMEF、PEF以及FEV1明顯高于對照組,兩組數據都比差異明顯,統計學有意義(P<0.05)。應用ACT對兩組治療前後治療效果進行評分,觀察組經過治療後由于對照組,兩組數據都比差異明顯,統計學有意義(P<0.05)。結論臨床中應用順爾寧聯閤舒利迭氣霧劑吸入治療支氣管哮喘穫得滿意的治療效果,值得臨床研究推廣使用。
목적:관찰순이저연합서리질기무제흡입치료지기관효천적치료효과,분석기개치。방법아원추취2012년1월지2013년11월도의원치료적지기관효천52례환자,안조불동방법평균분성량조:일조시대조조,령일조시관찰조,매조각26례환자。응용여포지내덕기무제흡입방법대대조조진행치료;응용순이저연합서리질기무제흡입대관찰조진행치료。결과관찰조화대조조폐공능지표변화정황,관찰조적MMEF、PEF이급FEV1명현고우대조조,량조수거도비차이명현,통계학유의의(P<0.05)。응용ACT대량조치료전후치료효과진행평분,관찰조경과치료후유우대조조,량조수거도비차이명현,통계학유의의(P<0.05)。결론림상중응용순이저연합서리질기무제흡입치료지기관효천획득만의적치료효과,치득림상연구추엄사용。
Objective To observe the Montelukast Combined with Seretide aerosol inhalation in treatment of bronchial asthma treatment effect, the analysis of its value.Methods In our hospital from January 2012 to November 2013 for treatment of 52 cases of bronchial asthma patients, according to the different methods are divided into two groups: one group is the control group, the other group is the observation group, each group had 26 patients. Application to Budesonide Aerosol inhalation treatment methods of the control group; the application of Singulair combined with Seretide in aerosol inhalation treatment on the observation group.Results The observation group and the control group lung function changes, the observation group MMEF, PEF and FEV1 were signiifcantly higher than those in control group, two groups of data are signiifcantly different, statistically signiifcant (P<0.05). Application of ACT in the two groups before and after treatment were observed, group after treatment as control group, two groups of data are signiifcantly different, statistically signiifcant (P<0.05).Conclusion The clinical application of Montelukast Combined with Seretide aerosol inhalation in treatment of bronchial asthma to obtain satisfactory curative effect, is worth the clinical research to promote.